# Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.

> **NCT02026947** · PHASE2 · WITHDRAWN · sponsor: **Niuvanniemi Hospital**

## Conditions studied

- Attenuated or Transient Psychosis

## Interventions

- **DRUG:** Sodium Benzoate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02026947
- **Lead sponsor:** Niuvanniemi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We did not commence the trial because there were no patients who could fulfill the inclusion criteria.
- **Last updated:** 2014-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02026947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02026947, "Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02026947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*